BRIEF published on 11/10/2025 at 18:10, 6 months 29 days ago Ascend's Innovation Enhances AAV Production Efficiency Gene Therapy Biotechnology Innovation Ascend Advanced Therapies AAV Production Manufacturing Enhancers
BRIEF published on 11/10/2025 at 18:10, 6 months 29 days ago L'innovation d'Ascend améliore l'efficacité de la production d'AAV Thérapie Génique Innovation En Biotechnologie Ascend Advanced Therapies Production AAV Améliorants De Fabrication
PRESS RELEASE published on 11/10/2025 at 18:05, 6 months 29 days ago Ascend Unveils Proprietary Enhancers That Significantly Improve AAV Yields Without Compromising Quality Ascend Advanced Therapies unveils proprietary enhancers demonstrating significant improvements in AAV yields and quality attributes for gene therapy programs Ascend Advanced Therapies Proprietary Enhancers AAV Yields Gene Therapy Programs Quality Attributes
BRIEF published on 10/08/2025 at 15:10, 8 months 1 day ago Ascend Advanced Therapies Successfully Defends EpyQ® Patent at EPO Intellectual Property Gene Therapy European Patent Office Ascend Advanced Therapies EpyQ® AAV Plasmid
BRIEF published on 10/08/2025 at 15:10, 8 months 1 day ago Ascend Advanced Therapies défend avec succès le brevet EpyQ® auprès de l'OEB Propriété Intellectuelle Thérapie Génique Office Européen Des Brevets Thérapies Avancées Ascend Plasmide AAV EpyQ®
PRESS RELEASE published on 10/08/2025 at 15:05, 8 months 1 day ago European Patent on Ascend Advanced Therapies' EpyQ® AAV Plasmid Technology Successfully Defended at the EPO Ascend Advanced Therapies successfully defends European patent EP3722434 for EpyQ® AAV plasmid technology at the EPO, reinforcing its position in gene therapy Gene Therapy European Patent Ascend Advanced Therapies EpyQ® AAV Plasmid Technology
Published on 06/10/2026 at 08:00, 2 hours 55 minutes ago Caledonia Mining Corporation Plc: Motapa Exploration Results
Published on 06/10/2026 at 00:00, 10 hours 55 minutes ago Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 11 hours 55 minutes ago NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 12 hours 25 minutes ago Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 13 hours 10 minutes ago Northfield Announces Change of Corporate Name to Juno International Corporation
Published on 06/10/2026 at 10:22, 32 minutes ago PNE AG: Narrowing of the coupon range to 7.000% to 7.500% for the new corporate bond 2026/2031
Published on 06/10/2026 at 10:10, 45 minutes ago LAMINAZIONE SOTTILE APPOINTS FABIO MARIA SGRAZZUTTI AS GROUP EXECUTIVE DIRECTOR
Published on 06/10/2026 at 10:10, 45 minutes ago NAKIKI SE is exploring a strategic investment in ecrop GmbH to expand its Bitcoin treasury strategy to include digital capital market infrastructure
Published on 06/10/2026 at 10:05, 50 minutes ago Green Street Infrastructure Research Now Available: Expanding Market Coverage Across Infrastructure Debt, Transport, and Data Centers
Published on 06/10/2026 at 10:00, 55 minutes ago REPLOID Group AG becomes official partner of the Bavarian Football Association (BFV)
Published on 06/10/2026 at 07:00, 3 hours 55 minutes ago Acceleration of Museum Studio's international expansion
Published on 06/10/2026 at 07:00, 3 hours 55 minutes ago Accélération de l'expansion mondiale de Museum Studio
Published on 06/09/2026 at 19:30, 15 hours 25 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 06/09/2026 at 19:30, 15 hours 25 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 16 hours 41 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/05/2026
